Skip to main content

Aptinyx Inc.

APTXDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001674365

Aptinyx Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 32 institutions reported holding it in 13F filings for Q1 2023, worth $2.44M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Aptinyx Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of APTX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders4035−5
Shares31.1M29.1M−2.01M (−6.5%)
Value$11.5M$8.33M−$3.15M (−27.5%)

New holders (4)

Institutions that held Aptinyx Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to APTX in Q4 2022
InstitutionSharesValue% of portfolio
Tower Research Capital LLC (TRC)27,095$8.00K0.00%
Citadel Advisors LLC25,973$7.61K0.00%
Concord Wealth Partners10,000$2.85K0.00%
Advisor Group Holdings, Inc.110$00.00%

Sold out (9)

Institutions that held Aptinyx Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of APTX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Ra Capital Management, L.P.1,954,698$720.0K
Bridgeway Capital Management, LLC124,041$46.0K
Assenagon Asset Management S.A.75,283$28.0K
Virtu Financial LLC23,806$9.00K
Gabelli Funds LLC10,901$4.00K
Two Sigma Securities, LLC10,873$4.00K
HRT Financial LP13,083$4.00K
Royal Bank of Canada432$0
Navigation Wealth Management, Inc.100$0